" class="no-js "lang="en-US"> Acuamark Diagnostics - Medtech Alert
Monday, October 07, 2024
Acuamark Diagnostics | Pharmtech Focus

Acuamark Diagnostics

About Acuamark Diagnostics

Acuamark Diagnostics

Acuamark Diagnostics is a biotechnology company focused on developing innovative technology for improved and cost-effective blood-based early-cancer screening for single cancer early detection and multi-cancer early detection. Backed by a highly experienced team of industry developers and scientific experts, it is AcuamarkDx’s mission to improve cancer management and increase survival by intercepting early-cancer more reliably, accessibly, and cost-effectively with its first-in-kind, high-throughput precision technology.

Related Story

Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection

July 22 2022

Acuamark Diagnostics (“AcuamarkDx”), an early cancer detection company, today announced the closing of an $11.3 million Series […]